Mitoxantrone and cardiac failure Patient Reports February 09, 2010

Mitoxantrone Side Effects Report #5235117-5
Mitoxantrone side effect was reported by a Consumer or non-health professional from CANADA on Jan 29, 2007. Female patient, 32 years of age, was diagnosed with relapsing-remitting multiple sclerosis and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: abdominal distension, cardiac failure, cardiogenic shock, cardiotoxicity, cough, disseminated intravascular coagulation, dyspnoea, hypotension. Mitoxantrone dosage: 8 MG/M2 MONTHLY UNK. Patient died on 01/01/2007.

Mitoxantrone Side Effects Report #4866891-5
Mitoxantrone side effect was reported by a Physician from BELGIUM on Dec 10, 2005. Female patient, 51 years of age, was diagnosed with multiple sclerosis  and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: bedridden, cardiac failure, chest pain , tricuspid valve incompetence. Mitoxantrone dosage: 12 MG/M2, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Mitoxantrone Side Effects Report #4866887-3
Mitoxantrone side effect was reported by a Physician from BELGIUM on Dec 10, 2005. Male patient, 39 years of age, was diagnosed with multiple sclerosis  and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: cardiac failure. Mitoxantrone dosage: unknown. Patient was hospitalized. Patient recovered.

Mitoxantrone Side Effects Report #4877364-8
Mitoxantrone side effect was reported by a Consumer or non-health professional from on Dec 22, 2005. Female patient, 56 years of age, was diagnosed with disease progression, multiple sclerosis  and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: aortic valve incompetence, aortic valve stenosis, cardiac failure, dilatation atrial, dilatation ventricular, mitral valve incompetence, pulmonary hypertension , sinus tachycardia, tricuspid valve incompetence. Mitoxantrone dosage: 12 MG/M2, 6 IN 6 CYCLE, INTRAVENOUS (NOT OHTERWISE SPECIFIED). Patient recovered.